Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice

Vaccine

Volumn 29, Issue 15, 2011, Pages 2749-2755

  Surendran, Naveen ^a   Sriranganathan, Nammalwar ^a   Lawler, Heather ^a   Boyle, Stephen M ^a   Hiltbold, Elizabeth M ^b   Heid, Bettina ^a   Zimmerman, Kurt ^a   Witonsky, Sharon G ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Brucella abortus; Intranasal vaccine; O side chain; Rough vaccine strains RB51 and RB51SOD

Indexed keywords

BRUCELLA VACCINE; SUPEROXIDE DISMUTASE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BAGG ALBINO MOUSE; BRUCELLA ABORTUS; BRUCELLOSIS; CATTLE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HOST PATHOGEN INTERACTION; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION; ZOONOSIS;

ANIMALS; BACTERIAL LOAD; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; FEMALE; IMMUNIZATION, SECONDARY; LUNG; MICE; MICE, INBRED BALB C; VACCINATION;

EID: 79952248185     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.090     Document Type: Article

References (17)

1. Zoonoses and communicable diseases common to man and animal 2001, Pan American Health Organization, WHO. P. Acha, B. Szyfres (Eds.).
2. Brucellosis in humans and animals 2006, World Health Organization. M.J. Corbel (Ed.).
3. Kahl-McDonagh M.M., Arenas-Gamboa A.M., Ficht T.A. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge. Infect Immun 2007, 75(October (10)):4923-4932.
4. Smither S.J., Perkins S.D., Davies C., Stagg A.J., Nelson M., Atkins H.S. Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis. Clin Vaccine Immunol 2009, 16(May (5)):779-783.
5. Pappas G., Panagopoulou P., Christou L., Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006, 63(October (19-20)):2229-2236.
6. Bossi P., Tegnell A., Baka A., Van Loock F., Hendriks J., Werner A., et al. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill 2004, 9(December (12)):E15-E16.
7. Jimenez de Bagues M.P., Elzer P.H., Jones S.M., Blasco J.M., Enright F.M., Schurig G.G., et al. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun 1994, 62(November (11)):4990-4996.
8. Bhattacharjee A.K., Izadjoo M.J., Zollinger W.D., Nikolich M.P., Hoover D.L. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Infect Immun 2006, 74(October (10)):5820-5825.
9. Mense M.G., Van De Verg L.L., Bhattacharjee A.K., Garrett J.L., Hart J.A., Lindler L.E., et al. Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis. Am J Vet Res 2001, 62(March (3)):398-405.
10. Olsen S.C., Waters W.R., Stoffregen W.S. An aerosolized Brucella spp. challenge model for laboratory animals. Zoonoses Public Health 2007, 54(8):281-285.
11. Pasquali P., Rosanna A., Pistoia C., Petrucci P., Ciuchini F. Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308. Infect Immun 2003, 71(May (5)):2326-2330.
12. Schurig G.G., Roop R.M., Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 1991, 28(July (2)):171-188.
13. Vemulapalli R., He Y., Cravero S., Sriranganathan N., Boyle S.M., Schurig G.G. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun 2000, 68(June (6)):3286-3289.
14. Mense M.G., Borschel R.H., Wilhelmsen C.L., Pitt M.L., Hoover D.L. Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta). Am J Vet Res 2004, 65(May (5)):644-652.
15. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006, 6(February (2)):148-158.
16. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002, 196(December (12)):1645-1651.
17. Ferrero M.C., Fossati C.A., Baldi P.C. Smooth Brucella strains invade and replicate in human lung epithelial cells without inducing cell death. Microbes Infect 2009, 11(April (4)):476-483.